Seven RI Companies Receive $314,930 in SBIR Phase I Matching Grants

Published on December 5, 2013

Seven Rhode Island companies are the first recipients of the Innovate Rhode Island Small Business Fund (IRISBF) matching grants for federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grant recipients.  These firms have already received over $1.2 million in federal funding from a competitive Phase I SBIR/STTR federal grant to develop technology that is of interest to a federal agency. The federal agencies benefiting from this research include the National Institutes of Health (NIH), National Science Foundation (NSF) and Department of Defense (U.S. Army and U.S. Air Force).

Companies receiving funding include 121 Nexus, Applied Radar Inc., Calista Therapeutics, CREmedical Corporation, Cytosolv, Epivax Inc. and Vision Systems Inc.

EpiVax, IncEpiVax, Inc., Providence, RI
Award amount: $45,000
Project description: Children with Pompe disease, a life threatening build-up of glycogen that damages muscles, often have an immune response to drugs to treat the condition. This project will further study the use of natural tolerance inducing peptides to increase the efficacy of existing treatments.

Earlier this year, the Rhode Island General Assembly created the IRISBF to foster job creation, facilitate small business development and….FULL ARTICLE HERE

Read about EpiVax’s Pompe’s research HERE